The emerging therapy of tirzepatide peptide represents a major development in the management of the condition. Distinct from existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – leading to greater blood sugar management and potential weight reduction. Scientists are studying its long-term bene